Excell Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.50 M
as on 23-10-2024
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.35 M
as on 23-10-2024
- Revenue 3.29%
(FY 2023)
- Profit 90.36%
(FY 2023)
- Ebitda 85.65%
(FY 2023)
- Net Worth 18.75%
(FY 2023)
- Total Assets 10.22%
(FY 2023)
About Excell Formulations
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹1.35 M, as per Ministry of Corporate Affairs (MCA) records.
Kausik Chakraborty, Bhaskar Chaudhuri, Hemant Hajare, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1995PTC087403
- Company No.
087403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 1995
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationThane, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Excell Formulations?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Hajare  | Director | 18-Apr-1995 | Current |
| Kausik Chakraborty | Director | 29-Jul-2011 | Current |
| Bhaskar Chaudhuri | Director | 29-Jul-2011 | Current |
| Ashok Singh | Director | 18-Apr-1995 | Current |
| Himanshu Kumar | Director | 19-Apr-1995 | Current |
Financial Performance of Excell Formulations.
Excell Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.29% increase. The company also saw a substantial improvement in profitability, with a 90.36% increase in profit. The company's net worth Soared by an impressive increase of 18.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Excell Formulations?
In 2023, Excell Formulations had a promoter holding of 91.00% and a public holding of 9.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Excellar Healthcare Private LimitedActive 17 years 9 monthsKausik Chakraborty, Bhaskar Chaudhuri and 3 more are mutual person
Pelfizz Biotech Private LimitedActive 20 years 7 monthsHemant Hajare and Ashok Singh are mutual person
- Aahar Associates (India) Private LimitedActive 22 years 6 months
Hemant Hajare and Ashok Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 20 May 2015 | ₹1.00 Cr | Open |
Axis Bank Limited Creation Date: 20 Aug 2009 | ₹1.35 M | Satisfied |
How Many Employees Work at Excell Formulations?
Unlock and access historical data on people associated with Excell Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excell Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excell Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
